Alba García-Baos

Alba García-Baos

Auto-generated profile, based on publicly available information

Alba García-Baos

Neurobiology of Behavior Research Group (GReNeC-NeuroBio), Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2019 in The Primary Care Companion For CNS Disorders
Verified
Journal Article
Closed access
AGAlba García-Baos
Alba García-Baos
TDTomas D’aMelio
Tomas D’aMelio
IOIsadora Oliveira
Isadora Oliveira
PCPeter Collins
Peter Collins
CECarme Echevarria
Carme Echevarria
HSHans Super
Hans Super
To assess whether the eye-tracking approach of the RECOGNeyes game has potential therapeutic benefits for children with neurodevelopmental disorders, in particular attention-deficit/hyperactivity disorder (ADHD). RECOGNeyes is a computer game that is played using the eyes as the game controller. The rationale behind the game is that individuals with ADHD have an underdeveloped attention control system. This attention control system is underdeveloped not because they lack this capacity but because this ability has not been sufficiently developed. The game was designed as an intervention for training visual attention in ADHD. The sample included 28 children aged 8-15 years (18 aged < 12 y and 10 aged ≥ 12 y) previously diagnosed with ADHD (DSM-5 criteria). The participants were randomly divided into 2 groups. The experimental group played RECOGNeyes with eye-tracker for 3 weeks (3 times/week) at home, while the control group played the game using the mouse. Different attentional parameters were assessed before and after training. The study was conducted from January 2018-June 2018. Participants from the eye-tracker group showed an improvement posttest compared to pretest in impulsivity (P = .0067), reaction time (P < .0001), and fixation gaze control (P < .0001). No changes were found in mouse control between pretest and posttest assessments. RECOGNeyes is a child-friendly, interactive game combined with eye-tracking technology that seems to provide an improvement in the visual attention system, which is especially indicated for ADHD patients. This game might be used as an alternative to pharmacologic therapy and may provide new insights into the treatment of ADHD.​.

25 July 2023 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
AGAlba Garcia-Baos
Alba Garcia-Baos
APAntoni Pastor
Antoni Pastor
IGInes Gallego-Landin
Ines Gallego-Landin
Renato TorreRenato Torre
Renato Torre
FSFerran Sanz
Ferran Sanz
OVOlga Valverde
Olga Valverde

25 July 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
LALaia Alegre-Zurano
Laia Alegre-Zurano
AGAlba García-Baos
Alba García-Baos
ACAdriana Castro-Zavala
Adriana Castro-Zavala
MMMireia Medrano
Mireia Medrano
IGInes Gallego-Landin
Ines Gallego-Landin
OVOlga Valverde
Olga Valverde
The endocannabinoid system is prominently implicated in the control of cocaine reinforcement due to its relevant role in synaptic plasticity and neurotransmitter modulation in the mesocorticolimbic system. The inhibition of fatty acid amide hydrolase (FAAH), and the resulting increase in anandamide and other N-acylethanolamines, represents a promising strategy for reducing drug seeking. In the present study, we aimed to assess the effects of the FAAH inhibitor URB597 (1 mg/kg) on crucial features of cocaine addictive-like behaviour in mice. Therefore, we tested the effects of URB597 on acquisition of cocaine (0.6 mg/kg/inf) self-administration, compulsive-like cocaine intake and cue-induced drug-seeking behaviour during withdrawal. URB597 reduced cocaine intake under conditioned punishment while having no impact on acquisition. This result was associated to increased cannabinoid receptor 1 gene expression in the ventral striatum and medium spiny neurons activation in the nucleus accumbens shell. Moreover, URB597 mitigated cue-induced drug-seeking behaviour during prolonged abstinence and prevented the withdrawal-induced increase in FAAH gene expression in the ventral striatum. In this case, URB597 decreased activation of medium spiny neurons in the nucleus accumbens core. Our findings evidence the prominent role of endocannabinoids in the development of cocaine addictive-like behaviours and support the potential of FAAH inhibition as a therapeutical target for the treatment of cocaine addiction.

17 March 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
AGAlba García-Baos
Alba García-Baos
XPXavi Puig-Reyne
Xavi Puig-Reyne
Oscar Garcia-AlgarOscar Garcia-Algar
Oscar Garcia-Algar
OVOlga Valverde
Olga Valverde
Summary: Foetal alcohol spectrum disorder (FASD) is the umbrella term used to describe the physical and mental disabilities induced by alcohol exposure during development. Early alcohol exposure induces cognitive impairments resulting from damage to the central nervous system (CNS). The neuroinflammatory response accompanied by neurodegenerative mechanisms contribute to those detrimental alterations. Cannabidiol (CBD) has recently emerged as an anti-inflammatory drug that might be useful to treat several neuropsychiatric disorders. In our study, we assessed the effects of CBD on long-lasting cognitive deficits induced by early alcohol exposure. Furthermore, we analysed long-term pro-inflammatory and apoptotic markers within the prefrontal cortex and hippocampus. To model alcohol binge drinking during gestational and lactation periods, we used pregnant C57BL/6 female mice with time-limited access to 20% v/v alcohol solution. Following the prenatal and lactation alcohol exposure (PLAE), we treated the male and female offspring with CBD from post-natal day (PD) 25 until PD34, and we evaluated their cognitive performance at PD60. Our results showed that CBD treatment during peri-adolescence period ameliorates cognitive deficits observed in our FASD-like mouse model, without sex differences. Moreover, CBD restores the PLAE-induced increased levels of TNFα and IL-6 in the hippocampus. Thus, our study provides new insights for CBD as a therapeutic agent to counteract cognitive impairments and neuroinflammation caused by early alcohol exposure.

21 January 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
AGAlba Garcia-Baos
Alba Garcia-Baos
APAntoni Pastor
Antoni Pastor
IGInes Gallego-Landin
Ines Gallego-Landin
Renato TorreRenato Torre
Renato Torre
FSFerran Sanz
Ferran Sanz
OVOlga Valverde
Olga Valverde
Background Patients diagnosed with fetal alcohol spectrum disorder (FASD) show persistent cognitive disabilities, including memory deficits. However, the neurobiological substrates of these deficits remain unclear. Here, we studied the participation of the expanded endocannabinoid system (ECS), which is known to be affected by alcohol in other life periods, and it is involved in memory impairments of neurodevelopmental disorders. Methods C57BL/6 female mice were exposed to a time-limited access to either water or alcohol to model prenatal and lactation alcohol exposure (PLAE). The expanded ECS was analyzed in the prefrontal cortex and the hippocampus of the offspring at post-partum day (PD) 25 and 70. Then, memory performance was tested after the repeated administration (from PD25 to PD34) of: i) URB597, to increase N-acylethanolamines (NAEs), and GW9662, a peroxisome proliferator-activated receptor gamma (PPAR-γ) antagonist; ii) pioglitazone, a PPAR-γ agonist. Finally, we used a viral approach to upregulate astrocytic PPAR-γ in the hippocampus to restore memory deficits. Results We report that PLAE causes a hippocampal reduction of NAEs and PPAR-γ at PD25. Moreover, URB597 suppresses PLAE-induced memory deficits through PPAR-γ, since its effects are prevented by GW9662. Direct PPAR-γ activation, using pioglitazone, also ameliorates memory impairments. Lastly, we demonstrate that the upregulation of PPAR-γ in hippocampal astrocytes is sufficient to rescue PLAE-induced memory deficits. Conclusion Our data reveal a bidirectional link between memory deficits and expanded ECS alterations in the context of early alcohol exposure. Furthermore, we proved that PPAR-γ in hippocampal astrocytes represents a specific therapeutic target for memory deficits in FASD.

6 May 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
AGAlba García-Baos
Alba García-Baos
IFIrene Ferreres-Álvarez
Irene Ferreres-Álvarez
IGInés Gallego-Landin
Inés Gallego-Landin
XPXavier Puig-Reyné
Xavier Puig-Reyné
ACAdriana Castro-Zavala
Adriana Castro-Zavala
AMAna Martín-Sánchez
Ana Martín-Sánchez
Postpartum depression (PPD) is a severe psychiatric disorder that affects up to 15% of mothers and impairs mother-infant bonding with devastating consequences on the child development and the mother health. Several studies indicate a possible dysregulation of glutamatergic and GABAergic signalling in the corticolimbic system, as well as a downregulation of the allopregnanolone levels in serum of PPD patients. Although brexanolone, an allopregnanolone-based treatment, has recently emerged as fundamental PPD treatment, there is scarce evidence on its neurobiological action mechanism. Moreover, ketamine appears to be a promising antidepressant treatment preventing PPD, nevertheless whether it might be a more effective than allopregnanolone for some patients remain unknown. Therefore, the present study is aimed to evaluate the depressive-like phenotype of postpartum females undergoing maternal separation with early weaning (MSEW) protocol, as well as to compare the effectiveness of ketamine and allopregnanolone treatments. MSEW dams show increased despair-like behaviour, anhedonia and disrupted maternal behaviour. Moreover, lower allopregnanolone serum levels, reduction of vesicular transporters for GABA (VGAT) and glutamate (VGLUT1) in the infralimbic cortex, as well as decreased hippocampal cellular proliferation are found in MSEW females. As for the antidepressant treatments, both drugs prevent despair-like behaviour, whereas only ketamine reverts anhedonia present in MSEW females. In addition, both treatments induce pro-neurogenic effects in the dorsal hippocampus but only allopregnanolone increases the VGAT and VGLUT1, without altering the excitatory/inhibitory ratio. Altogether, we propose a new mice model that recapitulates the core symptomatology and alterations in glutamatergic and GABAergic systems shown in PPD patients, which allows us to investigate the therapeutic mechanisms of allopregnanolone and ketamine.